Abstract:The development of Sanger sequencing and next-generation sequencing methods within the past few years have assisted investigators profile the diversity and relative abundances of heterogenous species in vector preparations. Especially Recombinant adeno-associated viruses (rAAVs), genome editing, and mRNA related research are currently the most prominently investigated platform in different area and essentially use for synthetic biology, gene and cell therapy, food industrial and medicinal pharmer etc. area. However, these types of research related constructs always contain high GC sequences, poly structure, long-length DNA sequences and ITR repeats sequences. Unfortunately, Sanger sequencing and NGS platforms may be inaccessible to investigators with limited resources, require large amounts of input material, or may require long wait times for sequencing and analyses. Recent advances with PacBio sequencing have helped to bridge the gap for quick and relatively inexpensive long-read sequencing needs. Specifically, long-read sequencing methods, like single molecule real-time (SMRT) sequencing, have been used to uncover truncations, chimeric genomes, and inverted terminal repeat (ITR) mutations in vectors. Recombinant adeno-associated virus (raav) is the most prominent platform in the field of current research, and its sequence is characterized by high GC, multi-structure, long sequence, genome, and repeat sequence. Sanger sequencing has certain defects in the detection of recombinant adeno-associated viruses. Meanwhile, Sanger needs to design sequencing primers based on known sequences to determine whether the sequences are correct. When sequence information is incomplete, it can only randomly design primers, obtain a sequence by luck, and then conduct the next round of sequencing. However, PacBio’s limitations and sample biases are not well-defined for sequencing. And sometimes the accuracy for base calling was low, resulting in a high degree of miscalled bases and false indels. These false indels led to read-length compression; thus, assessing heterogeneity based on read length is not advisable with current PacBio technologies. In this study, we explored the capacity for PacBio sequencing to directly interrogate content to obtain full-length resolution of encapsulated genomes. We found that the PacBio platform can cover the entirety of different type sequences like poly structure, long-length DNA fragment, high GC sequences and repeat sequences, especially the rAAV sequences from ITR to ITR without the need for pre-fragmentation. At the same time, the sequencing process was optimized to complete the sequencing of long difficult plasmids with the fewest plasmids and the fastest time. In summary, the optimization PacBio sequencing and novel bioinformation (BI) analysis method are able to correctly identify truncation hotspots in single-strand and self-complementary vectors using by SMRT sequencing and can serve as a rapid and low-cost alternative for proofing different type of sequences. ### Competing Interest Statement The authors have declared no competing interest.

Standardized Nomenclature and Reporting for PacBio HiFi Sequencing and Analysis of rAAV Gene Therapy Vectors

Direct ITR-to-ITR Nanopore Sequencing of AAV Vector Genomes

A Novel Next-Generation Sequencing and Analysis Platform to Assess the Identity of Recombinant Adeno-Associated Viral Preparations from Viral DNA Extracts

High-Throughput Quantification of In Vivo Adeno-Associated Virus Transduction with Barcoded Non-Coding RNAs

Orthogonal characterization of rAAV9 reveals unexpected transgene heterogeneity

Direct Pacbio sequencing methods and applications for different types of DNA sequences

9. rAAV Designs Harboring DNA Secondary Structures with High Thermal Stabilities Produce Heterogenic Viral Genome Populations

Characterization of AAV vectors: A review of analytical techniques and critical quality attributes

A dual‐reference study design for understanding and improving AAV genome size analysis

Evaluation of a rapid multi-attribute combinatorial high-throughput UV-Vis/DLS/SLS analytical platform for rAAV quantification and characterization

PCR-Based Analytical Methods for Quantification and Quality Control of Recombinant Adeno-Associated Viral Vector Preparations

Accurate Quantification of AAV Vector Genomes by Quantitative PCR

An optimized protocol for quality control of gene therapy vectors using nanopore direct RNA sequencing

High-Throughput In Vitro, Ex Vivo, and In Vivo Screen of Adeno-Associated Virus Vectors Based on Physical and Functional Transduction

Thorough molecular configuration analysis of non-canonical AAV genomes in AAV vector preparations

Identification of Broadly Applicable Adeno-Associated Virus Vectors by Systematic Comparison of Commonly Used Capsid Variants In Vitro

Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production

Querying Recombination Junctions of Replication-Competent Adeno-Associated Viruses in Gene Therapy Vector Preparations with Single Molecule, Real-Time Sequencing

Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants

A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system

An optimised protocol for quality control of gene therapy vectors using Nanopore direct RNA sequencing